Parkinson Disease Drug Market 2020 Clinical Reviews by Expert - Merck, Akorn, GSK, Novartis, Boehringer Ingelheim, Teva Pharmaceutical, Abbvie, Kyowa Hakko Kirin Pharma

Global Parkinson Disease Drug Market Size, Status and Forecast 2020-2026

Parkinson Disease Drug Market report will make detailed analysis mainly on in-depth research on the development environment, Market size, development trend, operation situation and future development trend of Parkinson Disease Drug Market on the basis of stating current situation of the industry in 2020.

Parkinson's disease is a progressive, degenerative neurological motor disorder, primarily affecting the dopaminergic cells of the brain. The symptoms of this disease include rigidity, tremor, bradykinesia and postural instability. The global Parkinson's disease drug market has witnessed remarkable growth in recent years owing to a large patient pool and increased diagnosis rates. According to the Parkinson's Disease Foundation, there are about 10 million people suffering from Parkinson's disease globally. Parkinson's, in terms of its presence, has a higher frequency in the developed countries. In the United States (U.S.), around 60,000 new cases are diagnosed with Parkinson's, each year.

Get Sample of this Report:
https://www.marketinsightsreports.com/reports/01131749963/global-parkinson-disease-drug-market-size-status-and-forecast-2020-2026/inquiry?source=OPENPR&Mode=NG23

The prominent players in the global Parkinson Disease Drug market are Merck, Akorn, GSK, Novartis, Boehringer Ingelheim, Teva Pharmaceutical, Abbvie, Kyowa Hakko Kirin Pharma, Astellas Pharma, Desitin Arzneimittel, Endo Pharmaceuticals, F.Hoffmann-La Roche, H.Lundbeck, Valeant, Apokyn, Orion, Stada Arzneimittel, US WorldMeds, Bausch Health

News and Latest Developments

July 16, 2019: Merck announced the decision to discontinue supplying the continuous release (CR) formulation of SINEMET® in the U.S. Sinemet is the brand name formulation of carbidopa/levodopa. SINEMET CR will continue to be available until the current inventory is depleted. This will not affect the immediate release formulation of SINEMET or the generic form of carbidopa/levodopa CR.

08/04/2011: Merck KGaA has finished enrolling patients in a late-stage clinical study of a drug for Parkinson's disease, the German drug maker said. Merck KGaA, which is a separate company from U.S.-based Merck & Co. and operates in the United States under the name EMD, said 549 patients with mid- to late-stage Parkinson's had enrolled in the phase-3 "SETTLE" study of safinamide.

Parkinson's disease is a chronic disorder that gradually leads to progressive deterioration of motor functions, caused by the loss of dopamine-producing brain cells. The Parkinson's disease drugs market is expected to witness significant growth, owing to the increasing cases of Parkinson's disease, with the growth in aging population levels. Therefore, it may drastically result in increasing the market size during the forecast period. Pharmaceutical firms are developing new and improved therapies for Parkinson's disease (PD), and recently, there have been some major product launches in Parkinson disease therapeutics and other assistive therapeutics. For instance, Adamas Pharmaceuticals' amantadine extended-release capsules / Gocovri launched in Jan 2018, which was the first drug indicated for dyskinesia developed due to long-term use of levodopa. Furthermore, most of the global firms have a robust drug pipeline for the treatment of Parkinson's disease, and as per the estimates, the forecast period may witness the launch of a few blockbuster drugs. Thus, it is boosting factor to the overall market growth.

Product Types for Parkinson Disease Drug Market Sinemet-CR, Trastal, Madopar, COMT Inhibitor, Other

Applications for Parkinson Disease Drug Market are Under 40 Years Old, 40-65 Years Old, Above 65 Years Old

(SPECIAL OFFER: UP TO 20% DISCOUNT ON PURCHASE)

Inquiry For Discount
https://www.marketinsightsreports.com/reports/01131749963/global-parkinson-disease-drug-market-size-status-and-forecast-2020-2026/discount?source=OPENPR&Mode=NG23

What our report offers:

Market share assessments for the regional and country level segments
Market share analysis of the top industry players
Strategic recommendations for the new entrants
Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

The research includes historic data from 2014 to 2020 and forecasts until 2026 which makes the report's an invaluable resource for industry executives, Marketing, Sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs.

For more information of this Reports:
https://www.marketinsightsreports.com/reports/01131749963/global-parkinson-disease-drug-market-size-status-and-forecast-2020-2026?Source=Openpr&Mode=NG23

Note: All the reports that we list have been tracking the impact of COVID-19 . Both upstream and downstream of the entire supplychain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team.

*If you need anything more than these then let us know and we will prepare the report according to your requirement.
Please connect with our sales team (sales@marketinsightsreports.com).

Contact US:
Irfan Tamboli (Head of Sales)-Market Insights Reports
Phone: + 1704 266 3234 | Mob: +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

About Us:
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.